Trademark: 90736220
Status Date
Wednesday, April 3, 2024
Filing Date
Wednesday, May 26, 2021
Published for Opposition
Tuesday, July 19, 2022
5 Medicinal preparations for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases, namely, viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors; Viral systems, gene therapy systems, nucleic acid delivery systems for medical purposes, namely, medicines for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; clinical medical reagents for use in nucleic acid based therapy, gene therapy, cell therapy, gene diagnosis and gene testing
44 Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; Consultancy in the field of pharmaceutics, namely, pharmaceutics in the field of gene therapy
42 Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics, namely, pharmaceutics in the field of gene therapy
Jan 27, 2023
Changes/Corrections After Pub Approval Entered
Jan 26, 2023
Extension Of Time To Oppose Process - Terminated
Jan 25, 2023
Assigned To Petition Staff
Jan 12, 2023
Teas Post Publication Amendment Received
Aug 18, 2022
Extension Of Time To Oppose Received
Jul 20, 2022
Teas Change Of Correspondence Received
Jul 20, 2022
Teas Change Of Domestic Representatives Address
Jul 20, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 20, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 19, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 19, 2022
Published For Opposition
Jun 29, 2022
Notification Of Notice Of Publication E-Mailed
Jun 13, 2022
Approved For Pub - Principal Register
May 31, 2022
Teas/Email Correspondence Entered
May 31, 2022
Correspondence Received In Law Office
May 31, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
May 28, 2022
Assigned To Lie
May 22, 2022
Teas Response To Suspension Inquiry Received
May 22, 2022
Teas Change Of Correspondence Received
May 22, 2022
Teas Change Of Domestic Representatives Address
May 22, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
May 22, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 10, 2022
Notification Of Letter Of Suspension E-Mailed
Feb 10, 2022
Letter Of Suspension E-Mailed
Feb 10, 2022
Suspension Letter Written
Feb 8, 2022
Assigned To Examiner
Aug 20, 2021
New Application Office Supplied Data Entered
May 29, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
